GLP-1 Receptor Agonist Use before Total Knee Arthroplasty is Associated with Lower Postoperative MI, DVT, and VTE Rates
The Journal of Knee Surgery · 22.10.2026
DOI: 10.1055/a-2982-7440 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Knee Surgery, erschienen am 22.10.2026. Verfasst von Bryan Yavari und 5 weiteren Autor:innen. Beteiligte Einrichtung: The University of Arizona College of Medicine - Phoenix, and Banner University Medical Center Phoenix, Department of Orthopedic Surgery, Arizona, Uni…. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for glycemic control and weight management, but their association with postoperative thrombotic events after total knee arthroplasty (TKA) remains unclear. We performed a retrospective cohort study using de-identified data from the TriNetX United States Collaborative Network, including adults who underwent primary TKA between December 1, 2006, and June 1, 2025. Patients with prior myocardial infarction (MI), deep vein thrombosis (DVT), venous thromboembolism (VTE), or pulmonary embolism (PE) were excluded. Exposure was defined as a prescription for a GLP-1 RA within 1 year and 1 day before surgery. A 1:1 propensity score match was performed on demographics, relevant comorbidities, and medications, yielding 11,765 patients in each cohort. Outcomes were postoperative MI, DVT, VTE, and PE. Compared with matched controls, patients prescribed GLP-1 RAs had a significantly lower risk of MI (25/11,246 vs. 47/11,171; risk ratio [RR] 0.528; 95% confidence interval [CI], 0.325–0.858). GLP-1 RAs use was also associated with a reduced risk of DVT (74/11,319 vs. 103/11,308; RR 0.718; 95% CI, 0.533–0.966) and VTE (133/11,040 vs. 172/11,027; RR 0.772; 95% CI, 0.617–0.967). In contrast, no statistically significant difference was observed in the incidence of PE between groups (49/11,352 vs. 58/11,382; RR 0.847; 95% CI, 0.580–1.238). Overall, preoperative GLP-1 RA use was associated with a significantly lower postoperative risk of MI, DVT, and VTE following TKA in this large, nationally representative cohort.
Autor:innen und Institutionen
- The University of Arizona College of Medicine - Phoenix, and Banner University Medical Center Phoenix, Department of Orthopedic Surgery, Arizona, United States, Phoenix.
- UT Southwestern Medical Center, Department of Physical Medicine and Rehabilitation, Texas, United States, Dallas.
Zitieren
APA
Yavari, B., Soltankhah, A., Eghrari, N., Calderon, S., Lederman, E., & Shah, A. (2026). GLP-1 Receptor Agonist Use before Total Knee Arthroplasty is Associated with Lower Postoperative MI, DVT, and VTE Rates. The Journal of Knee Surgery. https://doi.org/10.1055/a-2982-7440
Vancouver
Yavari B, Soltankhah A, Eghrari N, Calderon S, Lederman E, Shah A. GLP-1 Receptor Agonist Use before Total Knee Arthroplasty is Associated with Lower Postoperative MI, DVT, and VTE Rates. The Journal of Knee Surgery. 2026. doi:10.1055/a-2982-7440
BibTeX
@article{Yavari2026,
author = {Yavari, Bryan and Soltankhah, Aria and Eghrari, Nafis and Calderon, Stanna and Lederman, Evan and Shah, Anup},
title = {GLP-1 Receptor Agonist Use before Total Knee Arthroplasty is Associated with Lower Postoperative MI, DVT, and VTE Rates},
journal = {The Journal of Knee Surgery},
year = {2026},
doi = {10.1055/a-2982-7440}
}
EUVIMED